Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in

NCT05198479 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Nasopharyngeal Cancer

Interventions

RADIATION: 77 Lu-DOTA0-Tyr3-Octreotate

Sponsor

National Cancer Centre, Singapore

Collaborators

[object Object]
[object Object]